Disparities Between International Guidelines (AHA/ESC/ESVS/ESVM/SVS) Concerning Lower Extremity Arterial Disease: Consensus of the French Society of Vascular Medicine (SFMV) and the French Society for Vascular and Endovascular Surgery (SCVE).
Cardiovascular Agents
/ adverse effects
Consensus
Delphi Technique
Diet, Healthy
Endovascular Procedures
/ adverse effects
Evidence-Based Medicine
/ standards
Exercise Therapy
/ adverse effects
Healthcare Disparities
Humans
Lower Extremity
/ blood supply
Peripheral Arterial Disease
/ diagnostic imaging
Risk Reduction Behavior
Societies, Medical
Treatment Outcome
Vascular Surgical Procedures
/ adverse effects
Journal
Annals of vascular surgery
ISSN: 1615-5947
Titre abrégé: Ann Vasc Surg
Pays: Netherlands
ID NLM: 8703941
Informations de publication
Date de publication:
Apr 2021
Apr 2021
Historique:
received:
12
10
2020
accepted:
05
11
2020
pubmed:
29
12
2020
medline:
3
8
2021
entrez:
28
12
2020
Statut:
ppublish
Résumé
Several international guidelines concerning lower extremity arterial disease (LEAD) have been published recently, in particular, by the American Heart Association the European Society of Cardiology/European Society for Vascular Surgery, the European Society for Vascular Medicine and the Society for Vascular Surgery. These guidelines differ in some respects and certain issues are not addressed. The objective of this consensus driven by the French Societies of vascular Medicine and surgery was to analyze the disparities between the different guidelines, as well as certain issues not covered, and develop proposals with regard to these points. The following fields of LEAD have been explored: 1) classifications, 2) clinical evaluation, 3) diagnostic criteria, 4) quantification of arterial stenosis using duplex ultrasound, 5) detection of asymptomatic multisite lesions, 6) screening for LEAD in the context of cardiac disease, 7) medical treatment, 8) supervised exercise therapy, 9) revascularization and revascularization of the internal artery stenosis, 10) management of chronic limb ischemia, 11) longitudinal follow-up, and 12) diet.
Identifiants
pubmed: 33359707
pii: S0890-5096(20)31051-7
doi: 10.1016/j.avsg.2020.11.011
pii:
doi:
Substances chimiques
Cardiovascular Agents
0
Types de publication
Journal Article
Practice Guideline
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1-56Investigateurs
Thomas Behar
(T)
Xavier Bérard
(X)
Christophe Breteau
(C)
Dominique Brisot
(D)
Franck Chleir
(F)
Clarisse Choquenet
(C)
Raphael Coscas
(R)
Grégoire Detriché
(G)
Marie Elias
(M)
Khalil Ezzaki
(K)
Sandrine Fiori
(S)
Sébastien Gaertner
(S)
Catherine Gaillard
(C)
Céline Gaudout
(C)
Charles-Emmanuel Gauthier
(CE)
Yannick Georg
(Y)
Adrien Hertault
(A)
Elixène Jean-Baptiste
(E)
Marc Joly
(M)
Adrien Kaladji
(A)
Joëlle Laffont
(J)
Damien Laneelle
(D)
Jean-Pierre Laroche
(JP)
Anne Lejay
(A)
Anne Long
(A)
Tiphanie Loric
(T)
Anne-Laure Madika
(AL)
Betty Magnou
(B)
Jean-Patrick Maillard
(JP)
Julie Malloizel
(J)
Gilles Miserey
(G)
Alain Moukarzel
(A)
Claire Mounier-Vehier
(C)
Bahaa Nasr
(B)
Marie-Line Nelzy
(ML)
Philippe Nicolini
(P)
Jacques-Yves Phelipot
(JY)
Jean Sabatier
(J)
Gerhard Schaumann
(G)
Simon Soudet
(S)
Anne Tissot
(A)
Laurent Tribout
(L)
Jean-Claude Wautrecht
(JC)
Charles Zarca
(C)
Anne Zuber
(A)
Informations de copyright
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.